RxDoctor Payments Data

Haley McCracken

Family · Northport, ALNPI 1427610427

Payments from drug & device makers

$2,293in general payments, 2019–2025

Across 153 payments — averaging $14.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$527
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$382
  • Novartis$290
  • Boehringer Ingelheim$185
  • Corcept Therapeutics$171
  • Sanofi-aventis U.S. LLC$124
  • plus $615 from 18 others

What the payments were for

  • Food & beverage$2,293100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,293 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$38,231
Medicare patients
288
Services billed
688

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban34$34,253
JardianceEmpagliflozin19$17,250
MultaqDronedarone Hcl12$14,152
EntrestoSacubitril/Valsartan11$12,616
BrilintaTicagrelor14$12,164
Metoprolol Succinate56$1,752
Ezetimibe25$1,366
Carvedilol90$890
Digoxin14$590
Potassium Chloride21$380
Hydralazine Hcl17$344
ClopidogrelClopidogrel Bisulfate25$343
Amiodarone Hcl23$301
Atorvastatin Calcium22$247
Amlodipine Besylate36$245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$33$34,25334 claims
Boehringer IngelheimJardiance$185$17,25019 claims
Sanofi-aventis U.S. LLCMultaq$124$14,15212 claims
NovartisEntresto$290$12,61611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.

Other family in Northport

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →